I booked handsome AbbVie gains in the morning, a bird in hand is better than two in the bush.
I've seen this same pitch with Pfizer before, when Lipitor came off patent. I will mark my calendar to consider buying puts later part of 2015, depending on what % of revenue/profit Humira is at that time. If it's still around 50% of total revenue, then it's easy meat with puts. Pls do your own thinking before investing money